NCT02552732View on ClinicalTrials.gov

Nasal High Flow Therapy 30 Day Readmission Study

NATerminatedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

May 3, 2017

Study Completion Date

May 3, 2017

Conditions
Chronic Obstructive Pulmonary DiseaseCOPD
Interventions
DEVICE

NHF with or without Oxygen

NHF using myAIRVO™ 2 will be set at 25L/min at 37°C. However, all participants are able to lower the delivered temperature to 34°C.

Trial Locations (2)

6242

Medical Research Institute of New Zealand, Wellington

13088

Alana HealthCare, Liverpool

Sponsors
All Listed Sponsors
collaborator

Medical Research Institute of New Zealand

OTHER

collaborator

Alana Healthcare

UNKNOWN

lead

Fisher and Paykel Healthcare

INDUSTRY